See the Soliqua PI [sec 2.2] for the amount of lixisenatide with each dose of insulin
These are not all the possible side effects of Zepbound
They were originally created to help treat type 2 diabetes but are now also being used as a weight management drug
For semaglutide, 25.9% doubled their weight loss, 15.6% had some additional weight loss, and 14.6% maintained their initial loss, totaling 56.1% in the sustained or improved categories
According to DSM-5-TR criteria, BED severity is classified as mild (1-3 episodes/week), moderate (4-7 episodes/week), or severe (8+ episodes/week), with each level requiring appropriate treatment intensity
The model empowers patients, shortens the treatment journey, and opens new opportunities for digital engagement